Structured knowledge base of HIV-1/HIV-2.
First we calculate the prevalence of an amino acid at a position:
- Same amino acid at the same position from a single person is only
counted once. (
PATIENT_PER_MUT_COUNT
) - Multiple Amino acids at the same position from a single sample are not
counted. (
EXCLUDE_MIXTURES
) - Stop codons are not counted. (
EXCLUDE_STOP_CODONS
) - Sequences only used in unpublished studies are not used. (
PUBLISHED_ONLY
) - DNAChip Sequences are not used. (
NO_DNACHIP
) - Sequences with quality issues are not used. (
NO_QA_ISSUES
)
In general, an amino acid at a position with its prevalence < 0.01% is considered unusual, with the following exception:
- The amino acid is a known drug resistance mutation according to latest HIVDB algorithm.
A sequence falls in either of the conditions below is filtered.
Gene | APOBEC cutoff | Score cutoff | Min AA | Max AA |
---|---|---|---|---|
PR | >=2 | >=4 | >=31 | <=89 |
RT | >=3 | >=6 | >=66 | <=214 |
IN | >=3 | >=5 | >=67 | <=154 |
Score cutoff: the "score" here is defined as the total number of problematic mutations. A problematic mutation is defined either an APOBEC mutation or an unusual mutation.
PR | RT | IN | |
---|---|---|---|
# Total | 186116 | 189748 | 22868 |
# B | 102435 | 100064 | 12615 |
# Non-B | 83681 | 89684 | 10253 |
% Treated | 15.86% | 58.14% | 6.69% |
Please visit this page.